Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Gdansk
About this trial
The goal of this observational study is to learn about the effects of cholecalciferol administration, according to guidelines for the general population, on laboratory parameters of Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients, depending of the attained levels of vitamin D (25OH)D).
The main question it aims to answer is:
How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25(OH)D?
Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years.
Eligibility criteria
Qualifiers
CKD stage 5,dialysed patients with vitamin D deficiency or insufficiency (level of 25(OH)D < 30 ng/mL)
Disqualifiers
dialysis time of less than 3 months
inadequately controled secondary hyperparathyroidism (iPTH>800pg/mL)
treatment with calcimimetics
treatment with active forms of vitamin D3,
Trial design
Treatments tested in this trial
- Cholecalciferol
Treatment groups
160 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov